Cargando…

Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors

A new series of peptide-like derivatives containing different aromatic amino acids and possessing pharmacophores of COX-2 inhibitors as SO(2)Me or N(3 )attached to the para position of an end phenyl ring was synthesized for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. The synthetic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmaditaba, Mohammad Ali, Houshdar Tehrani, Mohammad Hassan, Zarghi, Afshin, Shahosseini, Sorayya, Daraei, Bahram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937080/
https://www.ncbi.nlm.nih.gov/pubmed/29755541
_version_ 1783320570877706240
author Ahmaditaba, Mohammad Ali
Houshdar Tehrani, Mohammad Hassan
Zarghi, Afshin
Shahosseini, Sorayya
Daraei, Bahram
author_facet Ahmaditaba, Mohammad Ali
Houshdar Tehrani, Mohammad Hassan
Zarghi, Afshin
Shahosseini, Sorayya
Daraei, Bahram
author_sort Ahmaditaba, Mohammad Ali
collection PubMed
description A new series of peptide-like derivatives containing different aromatic amino acids and possessing pharmacophores of COX-2 inhibitors as SO(2)Me or N(3 )attached to the para position of an end phenyl ring was synthesized for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. The synthetic reactions were based on the solid phase peptide synthesis method using Wang resin. One of the analogues, i.e., compound 2d, as the representative of these series was recognized as the most effective and the highest selective COX-2 inhibitor with IC(50) value of 0.08 μM and COX-2 selectivity index of 351.2, among the other synthesized compounds. Molecular docking study was operated to determine possible binding models of compound 2d to COX-2 enzyme. The study showed that the p-azido-phenyl fragment of 2d occupied inside the secondary COX-2 binding site (Arg(513), and His(90)). The structure-activity relationships acquired disclosed that compound 2d with 4-(azido phenyl) group as pharmacophore and histidine as amino acid gives the essential geometry to provide inhibition of the COX-2 enzyme with high selectivity. Compound 2d can be a good candidate for the development of new hits of COX-2 inhibitors.
format Online
Article
Text
id pubmed-5937080
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-59370802018-05-11 Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors Ahmaditaba, Mohammad Ali Houshdar Tehrani, Mohammad Hassan Zarghi, Afshin Shahosseini, Sorayya Daraei, Bahram Iran J Pharm Res Original Article A new series of peptide-like derivatives containing different aromatic amino acids and possessing pharmacophores of COX-2 inhibitors as SO(2)Me or N(3 )attached to the para position of an end phenyl ring was synthesized for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. The synthetic reactions were based on the solid phase peptide synthesis method using Wang resin. One of the analogues, i.e., compound 2d, as the representative of these series was recognized as the most effective and the highest selective COX-2 inhibitor with IC(50) value of 0.08 μM and COX-2 selectivity index of 351.2, among the other synthesized compounds. Molecular docking study was operated to determine possible binding models of compound 2d to COX-2 enzyme. The study showed that the p-azido-phenyl fragment of 2d occupied inside the secondary COX-2 binding site (Arg(513), and His(90)). The structure-activity relationships acquired disclosed that compound 2d with 4-(azido phenyl) group as pharmacophore and histidine as amino acid gives the essential geometry to provide inhibition of the COX-2 enzyme with high selectivity. Compound 2d can be a good candidate for the development of new hits of COX-2 inhibitors. Shaheed Beheshti University of Medical Sciences 2018 /pmc/articles/PMC5937080/ /pubmed/29755541 Text en © 2018 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ahmaditaba, Mohammad Ali
Houshdar Tehrani, Mohammad Hassan
Zarghi, Afshin
Shahosseini, Sorayya
Daraei, Bahram
Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors
title Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors
title_full Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors
title_fullStr Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors
title_full_unstemmed Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors
title_short Design, Synthesis and Biological Evaluation of Novel Peptide-Like Analogues as Selective COX-2 Inhibitors
title_sort design, synthesis and biological evaluation of novel peptide-like analogues as selective cox-2 inhibitors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937080/
https://www.ncbi.nlm.nih.gov/pubmed/29755541
work_keys_str_mv AT ahmaditabamohammadali designsynthesisandbiologicalevaluationofnovelpeptidelikeanaloguesasselectivecox2inhibitors
AT houshdartehranimohammadhassan designsynthesisandbiologicalevaluationofnovelpeptidelikeanaloguesasselectivecox2inhibitors
AT zarghiafshin designsynthesisandbiologicalevaluationofnovelpeptidelikeanaloguesasselectivecox2inhibitors
AT shahosseinisorayya designsynthesisandbiologicalevaluationofnovelpeptidelikeanaloguesasselectivecox2inhibitors
AT daraeibahram designsynthesisandbiologicalevaluationofnovelpeptidelikeanaloguesasselectivecox2inhibitors